hotspot -WSS

hotspot

author：entertainment 2025-10-02 23:31:04 - browse：175

Photography of the US department of health and human services in Silver Spring MD — Manuel Balce Ceneta/AP

An increasing number of medical device companies are submitting fabricated and unreliable data, the Food and Drug Administration noted Tuesday morning. The data comes from third-party labs hired by device firms to test the quality of their products.

Triple-check your data or we’ll reject your device, the FDA warned.

The goal of third-party testing is to ensure a device meets the FDA’s standards in a range of areas, including biocompatibility, sterility, and mechanical performance. The agency wrote that it has noticed an uptick in false data submissions in recent years, particularly from facilities based in China and India. In some cases, the facilities will send data copied from previous device submissions.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Security flaws in third

focus

WSS

STAT wants to know your pick for a great summer read or listen

Undocumented workers face uncertainty as immigration law takes effect in Florida

Advances in CAR

Hubble vs. James Webb telescope images: See the difference

NIH nominee Bertagnolli will get October confirmation hearing

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

entertainment

hotspot

hotspot

Sports medicine is finally prioritizing gender equality

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Walensky prepares to leave CDC — and Congress — behind

Vertex cell therapy lets patients with type 1 diabetes stop insulin

How one medical school became remarkably diverse

How generative AI is inspiring dreams of a health data revolution

Medical records are filled with copy

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Activists slam private health insurers over coverage restrictions

Stem cell treatment guidelines are released by FDA

knowledge

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Medicaid rebukes states for mistakenly disenrolling children

Snackable artificial intelligence, expert AI, and the pharma industry

What American doctors can learn from their Israeli counterparts

How Robert F. Kennedy Jr. distorted vaccine science

Medicaid rebukes states for mistakenly disenrolling children

entertainment

focus

focus

hotspot